Media Highlights and Announcements
Proactive InvestorsJune 27, 2022
A theatre of human innovation
For medtech entrepreneur and Artrya Ltd CEO John Barrington, every good solution to a problem starts with a clean sheet of paper and a little bit of human ingenuity.
StockheadJune 15, 2022
A big data approach to the early detection of heart disease
Stockhead host Peter Strachan discusses Artrya’s Salix technology and how through the use of big data and AI it can accurately detect markers and indicators of early heart disease.
Health IT AnalyticsMay 13, 2022
Huntsville Heart Center to Test AI-Based Cardiac Technology
Cardiac software provider Artrya is partnering with Huntsville Heart Center to test the efficacy of its AI-based technology in caring for cardiac patients.
AP NEWSMay 11, 2022
Artrya signs first U.S. Hospital Clinical Partnership with Huntsville Heart Center
Initial agreement includes comparison study of patient cardiac CT scans read by experts to those read by AI-based technology.
Proactive InvestorMay 09, 2022
Artrya shakes hands on first US clinical partnership with renowned heart hospital
Under an initial agreement, Huntsville Heart Center and Artyra will compare patient cardiac CT scans read by experts to those read by artificial intelligence (AI)-based technology.
Proactive InvestorMay 09, 2022
Artrya inks agreement with Huntsville Heart Center as first US-based clinical partnership
Artrya’s MD, John Barrington AM discusses the company’s first US partnership deal with Proactive’s Andrew Scott, detailing a clinical agreement with Huntsville Heart Center.
The West AustralianApril 22, 2022
Heart attacks in high-profile cricketers prompts warning from Perth cardiologist Professor Girish Dwivedi
A leading Perth cardiologist believes the recent spate of high-profile heart attacks should sound a warning about the increased health risks associated with modern living.
ArtryaApril 22, 2022
AI-Driven HealthTech
Ticker Insight News interviews John Barrington AM, on Artrya’s US expansion and the growing MedTech sector in Western Australia.
ProactiveApril 21, 2022
Artrya brings AI-driven heart disease diagnostic tool to the US market with subsidiary spin off
John Barrington discusses the company’s move into the US market, and its use of artificial intelligence in diagnosing early indicators for heart disease in clinical settings.
Medical Device News MagazineApril 20, 2022
Artrya Names US Cardiologist Dr. Nicolas Chronos to Advisory Board
Artrya Ltd announced the appointment of US Cardiologist Nicolas Chronos, MD, to its Clinical Advisory Board. He will promote key medical research partnerships and oversee US based research in support of Artrya’s US market entry.